West Michigan Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$705K Hold
8,074
0.16% 152
2026
Q1
$705K Sell
8,074
-142
-2% -$13.6K 0.16% 152
2025
Q4
$795K Buy
8,216
+315
+4% +$30.6K 0.18% 120
2025
Q3
$758K Sell
7,901
-413
-5% -$38K 0.18% 115
2025
Q2
$730K Buy
8,314
+599
+8% +$50.8K 0.21% 88
2025
Q1
$699K Sell
7,715
-574
-7% -$51.4K 0.23% 76
2024
Q4
$668K Sell
8,289
-103
-1% -$8.92K 0.2% 83
2024
Q3
$761K Sell
8,392
-111
-1% -$9.34K 0.23% 80
2024
Q2
$675K Sell
8,503
-21,770
-72% -$1.78M 0.21% 77
2024
Q1
$2.64M Buy
30,273
+1,306
+5% +$111K 0.86% 30
2023
Q4
$2.39M Buy
28,967
+6,135
+27% +$468K 0.9% 29
2023
Q3
$1.79M Buy
22,832
+574
+3% +$48.1K 0.96% 32
2023
Q2
$1.96M Buy
22,258
+5,722
+35% +$493K 0.78% 33
2023
Q1
$1.33M Buy
16,536
+6,805
+70% +$555K 0.76% 35
2022
Q4
$756K Buy
9,731
+113
+1% +$9.16K 0.55% 41
2022
Q3
$777K Buy
9,618
+292
+3% +$26.2K 0.68% 37
2022
Q2
$837K Buy
9,326
+911
+11% +$92.3K 0.72% 37
2022
Q1
$934K Buy
8,415
+1,720
+26% +$182K 0.63% 36
2021
Q4
$693K Buy
+6,695
New +$775K 0.52% 43

Other funds holding MDT

West Michigan Advisors's MDT Position: Q2 2026 in Review

West Michigan Advisors held its Medtronic (MDT) position steady in Q2 2026 at 8,074 shares worth $705K. The position accounts for 0.16% of the portfolio, ranked #152.

West Michigan Advisors first reported a position in MDT in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.64M in Q1 2024. 673 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • West Michigan Advisors held 8,074 shares of Medtronic worth $705K as of Q2 2026.
  • West Michigan Advisors left its Medtronic share count unchanged in Q2 2026.
  • Medtronic made up 0.16% of West Michigan Advisors's portfolio in Q2 2026, its #152 holding.
  • West Michigan Advisors first reported a position in Medtronic in Q4 2021 and has held it in 19 quarters since.
  • West Michigan Advisors's Medtronic position peaked at $2.64M in Q1 2024.
  • 673 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on West Michigan Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.